Healixa Receivables

The latest receivables for EMOR is $28K as of June 2026. That compares with $300K in the prior-year period — down 90.6% year over year. Investors often review this figure alongside Healixa's historical trend and sector peers before judging valuation or financial health.

Over the past year, EMOR's receivables moved from $300K to $28K — a 90.6% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Healixa's operating scale or balance-sheet position.

A receivables figure of $28K for EMOR is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting EMOR's receivables ($28K), review year-over-year change from $300K, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.